SAN ANTONIO (May 5, 2016) ― In a celebration of cancer survivorship, people from throughout San Antonio who are receiving cancer treatment or who have overcome cancer can run or walk for free in the Cancer Therapy & Research Center‘s “Give Cancer the Boot!” 5K Run/Walk.
The chip-timed run will begin at 8 a.m. on Saturday, May 14, at the UT Health Science Center San Antonio’s recreational running trail near Gold’s Gym, 7431 Merton Minter Drive, in the South Texas Medical Center.
“We hope that cancer survivors will come out and walk or run for as long as they are able with the hope that some will be well enough to complete the route,” said Mary Salazar, a CTRC nurse practitioner helping to organize the event.
The fee for family members, friends and community members is $20, which includes a T-shirt. “Our hope is that this fee will help recoup expenses for this initial run. If there are any profits, they will go to the CTRC’s Patient Assistance Fund, which provides wellness activities and specialized assistance for CTRC cancer patients,” Salazar said.
CTRC is part of the UT Health Science Center San Antonio, one of only four elite National Cancer Institute-designed cancer centers in Texas.
To register, cancer survivors should send an email to colemanrunningclub@gmail.com to obtain the special online sign-up code for free entry. Others may register at runsignup.com. Search for “Give Cancer the Boot!” Register online through 5 p.m. May 11 or onsite before the event May 14.
# # #
For current news from the UT Health Science Center San Antonio, please visit our newsroom, like us on Facebook, follow us on Twitter or view us on YouTube.
# # #
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.